Mark Crowther, MD, MSc, FRCPC, FRSC
Chair, Department of Medicine
Leo Pharma Chair in Thromboembolism Research
McMaster University
Hamilton, Ontario, Canada
Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
Professor of Pharmacy Practice and Science
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska, USA
Full Accreditation and Program Information
12:30pm
–
Registration & Lunch
12:45pm
–
Welcome & Introductions
12:49pm
–
Applicability of Real-World Evidence and Clinical Practice
1:06pm
–
Implementation of Real-World Evidence and Clinical Practice
1:22pm
–
Reversal Considerations in the Future
1:30pm
–
Bringing It All Together
Target Audience
This activity has been designed to meet the educational needs of the interprofessional team, including Hematology, Vascular Medicine, Vascular Surgery, Pulmonology/Critical Care, Neurology, Gastroenterology, Trauma, Hospital Medicine, Emergency Medicine, Cardiology, and Internal Medicine, as well as other clinicians involved in the management of patients on anticoagulation with life-threatening bleeding.
Learning Objectives
After completing this activity, the participant should be better able to:
- Evaluate recent practice-changing data that can be applied to practice in the presence of a life-threatening bleed in the presence of anticoagulation
- Apply the latest evidence-based approaches to maximize management prognostic outcomes for life-threatening bleeds in the presence of anticoagulation